Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Applied Molecular Transport Inc. Frequently Asked Questions
What is the ticker symbol for Applied Molecular Transport Inc.? What does AMTI stand for in stocks?
AMTI is the stock ticker symbol of Applied Molecular Transport Inc.. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Applied Molecular Transport Inc. (AMTI)?
As of Fri Dec 29 2023, market cap of Applied Molecular Transport Inc. is 10.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of AMTI stock?
You can check AMTI's fair value in chart for subscribers.
Is Applied Molecular Transport Inc. a good stock to buy?
The fair value guage provides a quick view whether AMTI is over valued or under valued. Whether Applied Molecular Transport Inc. is cheap or expensive depends on the assumptions which impact Applied Molecular Transport Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMTI.